FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation

A crucial aspect of ligand‐mediated receptor activation and shut‐down is receptor internalization and degradation. Here we compared the ubiquitylation of either wild type or a K508A ‘kinase‐dead’ mutant of fibroblast growth factor receptor 3 (FGFR3) with that of its naturally occurring overactive mutants, G380R as in achondroplasia, or K650E involved in thanatophoric dysplasia. Fibroblast growth factor receptors ubiquitylation was found to be directly proportional to their intrinsic tyrosine kinase activity, both of which could be blocked using kinase inhibitors. Despite excessive ubiquitylation, both overactive mutants failed to be efficiently degraded, even when challenged with ligand or overexpression of c‐Cbl, a putative E3 ligase. We conclude that phosphorylation is essential for FGFR3 ubiquitylation, but is not sufficient to induce downregulation of its internalization resistant mutants.

[1]  A. N. Meyer,et al.  Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[2]  Y. Yarden,et al.  c-Cbl Is a Suppressor of the Neu Oncogene* , 2000, The Journal of Biological Chemistry.

[3]  S. Ōmura,et al.  Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway , 1997, Molecular and cellular biology.

[4]  A. Yayon,et al.  Skeletal Dysplasia and Defective Chondrocyte Differentiation by Targeted Overexpression of Fibroblast Growth Factor 9 in Transgenic Mice , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  D. Donoghue,et al.  FGFR activation in skeletal disorders: too much of a good thing. , 1997, Trends in genetics : TIG.

[6]  D. Rotin,et al.  Ubiquitination and Endocytosis of Plasma Membrane Proteins: Role of Nedd4/Rsp5p Family of Ubiquitin-Protein Ligases , 2000, The Journal of Membrane Biology.

[7]  A. Ciechanover,et al.  The ubiquitin conjugation system is required for ligand‐induced endocytosis and degradation of the growth hormone receptor. , 1996, The EMBO journal.

[8]  D. Givol,et al.  Complexity of FGF receptors: genetic basis for structural diversity and functional specificity , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  D. Church,et al.  Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia , 1994, Cell.

[10]  R. Govers,et al.  The ubiquitin-proteasome system and endocytosis. , 1999, Journal of cell science.

[11]  L. Hicke.  Ubiquitin‐dependent internalization and down‐regulation of plasma membrane proteins , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  P. Prinos,et al.  A common FGFR3 gene mutation in hypochondroplasia. , 1995, Human molecular genetics.

[13]  D. Ornitz,et al.  Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia , 1996, Nature Genetics.

[14]  I. Lax,et al.  FRS2α attenuates FGF receptor signaling by Grb2- mediated recruitment of the ubiquitin ligase Cbl , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Brodsky,et al.  ER protein quality control and proteasome-mediated protein degradation. , 1999, Seminars in cell & developmental biology.

[16]  F. Doherty,et al.  Ubiquitinated protein conjugates are specifically enriched in the lysosomal system of fibroblasts , 1990, FEBS letters.

[17]  C. Deng,et al.  Fibroblast growth factor receptors (FGFRs) and their roles in limb development , 1999, Cell and Tissue Research.

[18]  A. Verkleij,et al.  Epidermal Growth Factor Induces Ubiquitination of Eps15* , 1997, The Journal of Biological Chemistry.

[19]  Arnold Munnich,et al.  Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia , 1994, Nature.

[20]  D. Bowtell,et al.  The Cbl protooncoprotein stimulates CSF‐1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation , 1999, The EMBO journal.

[21]  S. Mori.  [Ligand-induced polyubiquitination of receptor tyrosine kinases]. , 1995, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[22]  Ping Wang,et al.  Structure of a c-Cbl–UbcH7 Complex RING Domain Function in Ubiquitin-Protein Ligases , 2000, Cell.

[23]  R. Davis,et al.  The epidermal growth factor receptor is covalently linked to ubiquitin. , 1995, Oncogene.

[24]  Linda Hicke,et al.  Ubiquitin and proteasomes: Protein regulation by monoubiquitin , 2001, Nature Reviews Molecular Cell Biology.

[25]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[26]  P. Klint,et al.  Signal transduction by fibroblast growth factor receptors. , 1999, Frontiers in bioscience : a journal and virtual library.

[27]  C. Heldin,et al.  A tyrosine residue in the juxtamembrane segment of the platelet-derived growth factor beta-receptor is critical for ligand-mediated endocytosis. , 1994, The Journal of biological chemistry.

[28]  Z. Kam,et al.  c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.

[29]  D. Rimoin,et al.  Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 , 1995, Nature Genetics.

[30]  T. Hunter,et al.  The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. , 1999, Science.

[31]  W. Langdon,et al.  Cbl: many adaptations to regulate protein tyrosine kinases , 2001, Nature Reviews Molecular Cell Biology.

[32]  Howard Riezman,et al.  Ubiquitination of a Yeast Plasma Membrane Receptor Signals Its Ligand-Stimulated Endocytosis , 1996, Cell.

[33]  D. Ornitz,et al.  FGFs, heparan sulfate and FGFRs: complex interactions essential for development. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[34]  R. Adar,et al.  Differential Activation of Cysteine‐Substitution Mutants of Fibroblast Growth Factor Receptor 3 Is Determined by Cysteine Localization , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  M. Blagosklonny.  Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors , 2001, Oncogene.

[36]  A. Ciechanover,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[37]  D. Moscatelli,et al.  The FGF family of growth factors and oncogenes. , 1992, Advances in cancer research.

[38]  R. Adar,et al.  The Transmembrane Mutation G380R in Fibroblast Growth Factor Receptor 3 Uncouples Ligand-Mediated Receptor Activation from Down-Regulation , 2000, Molecular and Cellular Biology.

[39]  S. Hubbard,et al.  Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. , 1997, Science.

[40]  J. Aubin,et al.  Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line. , 1990, Developmental biology.

[41]  J. Bonifacino,et al.  Ubiquitin and the control of protein fate in the secretory and endocytic pathways. , 1998, Annual review of cell and developmental biology.

[42]  L. Hicke.  Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. , 1999, Trends in cell biology.

[43]  S. Rosengren,et al.  Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. , 2000, American journal of human genetics.

[44]  M. Goldfarb,et al.  Novel Recognition Motif on Fibroblast Growth Factor Receptor Mediates Direct Association and Activation of SNT Adapter Proteins* , 1998, The Journal of Biological Chemistry.

[45]  M. Muenke,et al.  Fibroblast-growth-factor receptor mutations in human skeletal disorders. , 1995, Trends in genetics : TIG.